UBS downgrades India stocks, lifts Taiwan on shifting tariff, growth outlook

UBS has downgraded Indian equities to "underweight," citing slowing domestic growth momentum, nominal GDP growth at a 25-year low, plateauing corporate returns, and stretched valuations exceeding 30 times forward earnings, placing India among the least attractive major emerging markets. Conversely, the firm upgraded Taiwan to "neutral" due to receding tariff risks for its technology exporters following U.S. Section 232 exemptions. UBS maintains an "overweight" position on China, while cautioning that global equity valuations are near historical highs.

Analysis

UBS has revised its emerging markets strategy, downgrading Indian equities to "underweight" while upgrading Taiwan to "neutral." The rationale for the India downgrade is multifaceted, citing a confluence of negative macroeconomic and market-specific factors. Analysts point to nominal GDP growth reaching a 25-year low, a stagnation in corporate returns, and critically, stretched valuations exceeding 30 times forward earnings. This has eroded India's growth premium over its peers, making it one of the least attractive major emerging markets in UBS's view. A key differentiator highlighted is the absence of clear artificial intelligence beneficiaries within India's listed market, a stark contrast to the opportunities present in China, Taiwan, and Korea. Conversely, Taiwan's upgrade to "neutral" is predicated on receding geopolitical risks, specifically the easing of U.S. tariff threats for its crucial technology export sector following Section 232 exemptions. Despite this improved outlook for firms like TSMC, UBS refrains from an "overweight" rating due to concerns about cyclical peaks in technology sector earnings and valuations. The firm maintains its "overweight" conviction on China, supported by improving fundamentals and early indicators of a structural shift in household savings from bank deposits into equities. Overall, UBS projects a modest 4-6% upside for emerging markets by December 2026, but tempers this outlook with a caution that global equity valuations are approaching historical highs.

Key Decisions for Investors

• Investors should review their exposure to Indian equities, as the combination of slowing domestic growth, plateauing corporate returns, and valuations over 30x forward earnings presents a significant risk, according to UBS's 'underweight' thesis.
• Consider the improved risk profile for Taiwanese technology exporters like TSMC due to easing tariff concerns, but remain cautious of cyclically high earnings and valuations when timing new or additional positions.
• Evaluate opportunities to increase allocation to Chinese equities, as UBS's 'overweight' stance is backed by improving fundamentals and a potential domestic capital rotation into the stock market.
• A strategic portfolio rotation within emerging markets may be warranted, potentially reducing weight in India and reallocating towards China or tactically to Taiwan, reflecting the divergent outlooks presented by the analysis.